Interestingly, the level of CD133+ cells, as determined by immunofluorescence, in tumor explants appeared to be enriched with sequential serial transplantation of the tumor cells although this apparent increase in CD133 levels was not consistently detected by flow cytometry. This evidence concerns the gene PROM1 and neoplasm.